Repligen Research and Development Expenses 2010-2024 | RGEN
Repligen research and development expenses for the twelve months ending September 30, 2024 were $0.042B, a 4% decline year-over-year.
- Repligen annual research and development expenses for 2023 were $0.043B, a 2.76% decline from 2022.
- Repligen annual research and development expenses for 2022 were $0.044B, a 28.19% increase from 2021.
- Repligen annual research and development expenses for 2021 were $0.034B, a 69.82% increase from 2020.